Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Haemonetics Corp (NY: HAE )

88.97 +3.42 (+4.00%)
Streaming Delayed Price Updated: 2:54 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Haemonetics Corp

< Previous 1 2 3 4 5 Next >
Morgan Stanley Maintains Equal-Weight Rating for Haemonetics: Here's What You Need To Know
Morgan Stanley has decided to maintain its Equal-Weight rating of Haemonetics (NYSE:HAE) and raise its price target from $60.00 to $70.00. Shares of Haemonetics are trading up 1.46% over the last 24... 
Via Benzinga
4 Analysts Have This to Say About Haemonetics
Over the past 3 months, 4 analysts have published their opinion on Haemonetics (NYSE:HAE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Needham Sees Reasonable Forecasts For Haemonetics, With Some Tailwinds
Haemonetics Corporation's (NYSE: HAE) analyst day later this month may include an update on its businesses, new products, margin outlook, and financial targets for FY24-FY26. 
Via Benzinga
ShockWave Medical Stock Shows Rising Price Performance With Jump To 91 RS Rating
On Monday, ShockWave Medical stock received an upgrade to its Relative Strength (RS) Rating, from 86 to 91. 
Via Investor's Business Daily
The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More
Biotech stocks declined yet again in the week ending May 6, dragged lower by macroeconomic concerns following the Federal Reserve's 50-basis-point rate hike. The iShares Biotechnology ETF (NASDAQ:... 
Via Benzinga
Analyst Ratings For Haemonetics
Analysts have provided the following ratings for Haemonetics (NYSE:HAE) within the last quarter: 
Via Benzinga
Why Haemonetics Shares Are Trading Higher Today?
Haemonetics Corporation (NYSE: HAE) posted  
Via Benzinga
103 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Haemonetics: Q4 Earnings Insights
Haemonetics (NYSE:HAE) reported its Q4 earnings results on Tuesday, May 10, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Recap: Haemonetics Q3 Earnings
  Haemonetics (NYSE:HAE) reported its Q3 earnings results on Tuesday, February 8, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
77 Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
10 Biggest Price Target Changes For Wednesday
Cowen & Co. cut the price target on Chipotle Mexican Grill, Inc. (NYSE: CMG) from $2,250 to $1,950. Chipotle shares rose 6.1% to $1,549.97 in pre-market trading. 
Via Benzinga
51 Biggest Movers From Yesterday
Also check out this: Apple And 3 Other Stocks Sold By Insiders Losers SelectQuote, Inc. (NYSE: SLQT) shares tumbled 47.3% to close at $3.44 on Tuesday after the company... 
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Surges 100 Points; Graham Shares Plunge
US stocks extended gains later in the session, with the Nasdaq index surging 100 points on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers BioCardia (NASDAQ:BCDA) stock inc... 
Via Benzinga
Mid-Day Market Update: Pfizer Sales Miss Expectations; Teradata Shares Spike Higher
US stocks remained mostly higher on Tuesday, while the S&P 500 traded lower by 0.1%. 
Via Benzinga
35 Stocks Moving In Tuesday's Mid-Day Session
Gainers Society Pass Incorporated (NASDAQ: SOPA) gained 63.4% to $3.45 after dropping 16% on Monday. American Rebel Holdings, Inc. (NASDAQ: AREB) climbed 56.1% to $3.45 following... 
Via Benzinga
The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Earnings Scheduled For February 8, 2022
Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion. 
Via Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big... 
Via Benzinga
64 Biggest Movers From Yesterday
Check out these penny stocks insiders are buying Losers ION Geophysical Corporation (NYSE: IO) shares fell 53.6% to settle at $0.51 on Thursday. Epizyme, Inc. (NASDAQ:... 
Via Benzinga
46 Stocks Moving In Thursday's Mid-Day Session
Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 158.2% to $7.23 after tumbling 18% on Wednesday. Indonesia Energy said it projects to commence drilling... 
Via Benzinga
75 Biggest Movers From Yesterday
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep. Check out these big penny stock gainers and losers... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2022
Upgrades 
Via Benzinga
Why Haemonetics Stock Dived by 15% Today
The company broadly meets expectations for its Q2 2022 but trims its full-year guidance. 
Via The Motley Fool
Haemonetics Corp (HAE) Q2 2022 Earnings Call Transcript
HAE earnings call for the period ending October 2, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE: 
Via Benzinga
58 Stocks Moving In Monday's Mid-Day Session
Gainers Dover Motorsports, Inc. (NYSE: DVD) shares climbed 60.3% to $3.59 after Speedway Motorsports announced it will acquire the company for $3.61 per share in cash. TDH... 
Via Benzinga
Looking Into Haemonetics's Return On Capital Employed
According to Benzinga Pro, during Q2, Haemonetics (NYSE:HAE) earned $24.51 million, a 398.43% increase from the preceding quarter. Haemonetics also posted a total of $239.90... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Compass Pathways (NASDAQ:CMPS) shares rose 18.43% to $51.0 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. As per the... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback